Windlas Biotech Limited (NSE:WINDLAS)
India
· Delayed Price · Currency is INR 971.00
+14.80 (1.55%)
May 22, 2025, 3:29 PM IST
Windlas Biotech Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2018 - 2019 |
| Net Income | 581.87 | 426.26 | 380.89 | 158.32 | 162.13 | Upgrade
|
| Depreciation & Amortization | 131.98 | 121.66 | 119.26 | 124.66 | 90.12 | Upgrade
|
| Other Amortization | 2.46 | 1.98 | 2.21 | 4.99 | 2.81 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.06 | -8.76 | -0.1 | -0.09 | 0.08 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 0.08 | - | 286.64 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | -108.21 | -47.82 | -17.24 | -62.22 | -13.8 | Upgrade
|
| Loss (Gain) on Equity Investments | - | - | - | 1.73 | 74.5 | Upgrade
|
| Stock-Based Compensation | 20.67 | 10.08 | 18.13 | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | 27.49 | 22.75 | 3.48 | 10.62 | 0.95 | Upgrade
|
| Other Operating Activities | -6.13 | 20.22 | -39.65 | -9.72 | -31.43 | Upgrade
|
| Change in Accounts Receivable | -198.35 | -83.63 | -316.73 | -148.35 | -26.06 | Upgrade
|
| Change in Inventory | 125.49 | -160.28 | -172.49 | 100.7 | -302.9 | Upgrade
|
| Change in Accounts Payable | 437.68 | 245.12 | 233.04 | -460.39 | 252 | Upgrade
|
| Change in Other Net Operating Assets | 74.71 | 61.99 | -119.5 | 107.65 | 41.65 | Upgrade
|
| Operating Cash Flow | 1,090 | 609.65 | 91.3 | 114.54 | 250.06 | Upgrade
|
| Operating Cash Flow Growth | 78.72% | 567.74% | -20.29% | -54.20% | 34.05% | Upgrade
|
| Capital Expenditures | -376.84 | -708.9 | -148.04 | -58.47 | -153.1 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.42 | 9.1 | 1.1 | 0.15 | 0.14 | Upgrade
|
| Cash Acquisitions | - | - | - | -1,035 | - | Upgrade
|
| Investment in Securities | -561.67 | 513.2 | -1,424 | 874.72 | 0.36 | Upgrade
|
| Other Investing Activities | 17.41 | 45.5 | 25.62 | 16.62 | 9.19 | Upgrade
|
| Investing Cash Flow | -920.68 | -141.1 | -1,546 | -201.98 | -143.41 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 84.6 | 38.66 | Upgrade
|
| Total Debt Issued | - | - | - | 84.6 | 38.66 | Upgrade
|
| Short-Term Debt Repaid | -2.26 | -53.42 | -248.07 | - | - | Upgrade
|
| Long-Term Debt Repaid | -16.33 | -16.52 | -9.05 | -50.45 | -67.77 | Upgrade
|
| Total Debt Repaid | -18.59 | -69.94 | -257.12 | -50.45 | -67.77 | Upgrade
|
| Net Debt Issued (Repaid) | -18.59 | -69.94 | -257.12 | 34.15 | -29.11 | Upgrade
|
| Issuance of Common Stock | - | - | 1,650 | - | - | Upgrade
|
| Repurchase of Common Stock | -40.23 | -271.93 | - | - | - | Upgrade
|
| Common Dividends Paid | -83.01 | -76.28 | - | - | - | Upgrade
|
| Other Financing Activities | -11.07 | -19.24 | -92 | -26.39 | -25.31 | Upgrade
|
| Financing Cash Flow | -152.9 | -437.39 | 1,301 | 7.76 | -54.42 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | - | - | 58.2 | - | Upgrade
|
| Net Cash Flow | 16.02 | 31.16 | -153.6 | -21.48 | 52.23 | Upgrade
|
| Free Cash Flow | 712.76 | -99.25 | -56.74 | 56.07 | 96.96 | Upgrade
|
| Free Cash Flow Growth | - | - | - | -42.17% | -0.04% | Upgrade
|
| Free Cash Flow Margin | 11.30% | -1.93% | -1.22% | 1.31% | 2.95% | Upgrade
|
| Free Cash Flow Per Share | 34.15 | -4.59 | -2.77 | 3.08 | 5.33 | Upgrade
|
| Cash Interest Paid | 11.07 | 7.87 | 14.15 | 13.65 | 25.31 | Upgrade
|
| Cash Income Tax Paid | 186.48 | 97.16 | 88.8 | 65.32 | 134.25 | Upgrade
|
| Levered Free Cash Flow | 629.88 | -124.53 | -167.52 | -154.28 | -15.56 | Upgrade
|
| Unlevered Free Cash Flow | 636.79 | -119.6 | -158.67 | -146.21 | 0.23 | Upgrade
|
| Change in Net Working Capital | -453.97 | -156.39 | 401.95 | 488.73 | 140.92 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.